European Journal of Radiology
Volume 39, Issue 3 , Pages 168-175 , September 2001

MRI staging using gadodiamide for soft-tissue tumors of the head and neck region. Results from a phase II trial and a 5-year clinical follow-up

  • S.E Ekholm

      Affiliations

    • Department of Diagnostic Radiology, Sahlgrenska University Hospital, MR Center, P.O. Box 75014, SE-40036 Göteborg, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46-31-604-098; fax: +46-31-411-673
    • ,
  • T Björk-Eriksson

      Affiliations

    • Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden
    • ,
  • A Western

      Affiliations

    • Nycomed Imaging AS, Clinical R&D, Oslo, Norway
    • ,
  • H Nellström

      Affiliations

    • Department of Diagnostic Radiology, Sahlgrenska University Hospital, MR Center, P.O. Box 75014, SE-40036 Göteborg, Sweden
    • ,
  • E Jonsson

      Affiliations

    • Nycomed AB, Stockholm, Sweden
    • ,
  • A Johansson

      Affiliations

    • Department of Diagnostic Radiology, Sahlgrenska University Hospital, MR Center, P.O. Box 75014, SE-40036 Göteborg, Sweden
    • ,
  • L Lönn

      Affiliations

    • Department of Diagnostic Radiology, Sahlgrenska University Hospital, MR Center, P.O. Box 75014, SE-40036 Göteborg, Sweden
    • ,
  • C Mercke

      Affiliations

    • Department of Oncology, Sahlgrenska University Hospital, Göteborg, Sweden
    • ,
  • P.O Tollesson

      Affiliations

    • Department of Diagnostic Radiology, Sahlgrenska University Hospital, MR Center, P.O. Box 75014, SE-40036 Göteborg, Sweden

Received 3 November 1998 ,Revised 23 March 1999 ,Accepted 24 March 1999.

References 

  1. Vogl TJ, Dresel SHJ, Späth M, Grevers G, Wilimzig C, Schedel HK, et al. Parotid gland: plain and gadolinium-enhanced MR imaging. Radiology. 1990;177:667–674
  2. Zoarski GH, Lufkin RB, Bradley WG, Flanders AE, Gale DR, Harms SE, et al.  Multicenter trial of gadoteridol, a nonionic gadolinium chelate, in patients with suspected head and neck pathology. Am. J. Neuroradiol. 1993;14(4):955–961
  3. Vogh TH, Dresel S, Juergens M, Assal J, Lissner J. MR imaging with Gd-DTPA in lesions of the head and neck. J. Otolaryngol. 1993;22(4):220–230
  4. Schraepen T, Winters V, Bijnens E, Broeckx J. Schwannoma of the trachea. J. Belge Radiol. 1997;80(4):161–162
  5. International Union Against Cancer . In: TNM classification of malignant tumours. 4th ed. Heidelberg: Springer-Verlag; 1987;p. 14–15 also pp. 27–29
  6. Geigy Scientific Tables, vol. 2, 1982.
  7. Sigal R. Oral cavity, oropharynx, and salivary glands. In:  Yousem DM editors. 2nd ed. Neuro-Imaging Clinics of North America. Head and Neck Imaging. 6:New York: W.B. Saunders; 1996;p. 379–400
  8. Tamler BI, Kligerman MM. Diagnostic imaging aids to head and neck radiation oncology. In:  Yousem DM editors. 2nd ed. Neuro-Imaging Clinics of North America. Head and Neck Imaging. 6:New York: W.B. Saunders; 1996;p. 515–530
  9. King AD, Lam WW, Leung SF, Chan YL, Metreweli C. Comparison of T2 weighted fat suppressed turbo spin echo and contrast enhanced T1 weighted spin echo MRI in nasopharyngeal carcinoma. Br. J. Radiol. 1997;70(840):1208–1214
  10. Einspieler R, Ebner F, Posawetz W, Ranner G, Fluckiger F, Lammer J. MR-imaging with Gd-DTPA in carcinomas of tongue, oro-hypopharynx. Eur. J. Radiol. 1991;13(1):21–26
  11. Zoarski GH, Parker JR, Lufkin RB, Harnsberger HR, Rhoda CH. Efficacy of gadoteridol for magnetic resonance imaging of extracranial head and neck pathology. Invest. Radiol. 1992;1:S53–57

PII: S0720-048X(01)00371-0

European Journal of Radiology
Volume 39, Issue 3 , Pages 168-175 , September 2001

Article Tools

* Image Usage & Resolution